Table 3 Outcomes in COVID-19 and influenza patients according to Herpesviridae reactivations
No Herpesviridae reactivation N = 81 | HSV reactivation N = 67 | CMV reactivation N = 24 | HSV and CMV reactivation N = 62 | |||||
|---|---|---|---|---|---|---|---|---|
COVID-19 N = 52 | Influenza N = 29 | COVID-19 N = 32 | Influenza N = 35 | COVID-19 N = 20 | Influenza N = 4 | COVID-19 N = 41 | Influenza N = 21 | |
Duration of MV, days | 23 (13–47) | 22 (9–34) | 44 (32–56) | 22 (14–53) | 58 (35–75) | 40 (23–53) | 57 (44–67) | 50 (20–69) |
ICU length of stay, days | 30 (19–50) | 24 (9–35) | 54 (39–70) | 23 (10–55) | 67 (47–89) | 26 (15–42) | 58 (47–72) | 40 (17–73) |
ICU mortality | 21 (40) | 13 (45) | 12 (38) | 17 (49) | 8 (40) | 3 (75) | 22 (54) | 11 (52) |